Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660098 · ClinicalTrials.gov registry record
Mirror Box Therapy As a Treatment Option for Functional Movement Disorders
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 14
- Enrollment target
NCT03660098: Completed study, sponsored by The Cleveland Clinic.
NCT03660098 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03660098 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the potential of using mirror box therapy as a therapeutic technique amongst patients with functional movement disorders. It is hypothesized that a brief, single, in-office mirror therapy session will lead to a noticeable decrease in FMD-related involuntary movements.
Primary Outcome
The difference in scored movement severity in the more affected hand based on the modified s-FMDRS scale during the Unified Parkinson's Disease Rating Scale (UPDRS) exam after the exercises with vs. without the mirror box. Movements are scored by video raters on a scale of 0-3, and higher score indicates more severe movement.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2022-05-17 |
What the finished NCT03660098 record still lists
NCT03660098 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03660098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03660098 about?
NCT03660098 is a clinical study titled "Mirror Box Therapy As a Treatment Option for Functional Movement Disorders". The purpose of this study is to investigate the potential of using mirror box therapy as a therapeutic technique amongst patients with functional movement disorders. It is hypothesized that a brief, single, in-office mirror therapy session will lead to a noticeable decrease in FMD-related involuntar...
What is the current status of trial NCT03660098?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2018-06-28. Estimated completion is 2022-05-17.
Who is sponsoring clinical trial NCT03660098?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy